株洲千金药业股份有限公司2025年第二次临时股东大会决议公告

Group 1 - The second extraordinary general meeting of shareholders was held on November 17, 2025, at the company's headquarters in Zhuzhou [2][3] - All resolutions presented at the meeting were approved without any objections [2] - The meeting was convened in accordance with the Company Law and the company's articles of association, with the chairman presiding over the session [2][3] Group 2 - All eight current directors attended the meeting, with independent directors participating via telecommunication [3] - A special resolution to cancel the supervisory board, change the registered capital, and amend the articles of association was passed with over two-thirds of the voting rights [3][4] - The meeting was witnessed by lawyers from Hunan Qiyuan Law Firm, confirming the legality of the meeting's procedures and resolutions [4]